Zylox Medical Device Co
Zylox Medical Device Co., a leading innovator in the medical technology sector, is headquartered in China (CN) and operates extensively across Asia and Europe. Founded in 2010, the company has rapidly established itself as a key player in the development of advanced medical devices, particularly in the fields of minimally invasive surgery and diagnostic imaging. Zylox is renowned for its cutting-edge products, including state-of-the-art endoscopic systems and precision surgical instruments, which are designed to enhance patient outcomes and streamline surgical procedures. The company’s commitment to quality and innovation has earned it numerous accolades, solidifying its position as a trusted name in the medical device industry. With a focus on research and development, Zylox continues to push the boundaries of technology, ensuring it remains at the forefront of medical advancements.
DitchCarbon Score
How does Zylox Medical Device Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zylox Medical Device Co's score of 19 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zylox Medical Device Co's reported carbon emissions
In 2023, Zylox Medical Device Co reported total carbon emissions of approximately 3,291,740 kg CO2e, with Scope 1 emissions at about 279,920 kg CO2e and Scope 2 emissions at around 3,011,820 kg CO2e. This marks an increase from 2022, where total emissions were about 3,069,870 kg CO2e, comprising approximately 137,290 kg CO2e in Scope 1 and about 2,932,580 kg CO2e in Scope 2. Zylox has not disclosed any specific reduction targets or initiatives as part of their climate commitments. The company has reported emissions data for Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. The absence of defined reduction targets suggests that while Zylox is tracking its emissions, it may not yet have formalised a comprehensive strategy for reducing its carbon footprint. Overall, Zylox Medical Device Co's emissions reflect the challenges faced by the medical device industry in managing carbon outputs, particularly in the context of increasing production and revenue.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 20,840 | 000,000 | 000,000 |
| Scope 2 | 1,384,300 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zylox Medical Device Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
